Moberg Pharma AB

Moberg Pharma AB
Stock Exchange OTC Publication Venue
EPS
SEK1.49
Market Cap
SEK1.17 B
Shares Outstanding
17.7 M
Public Float
14.33 M

Profile

Address
Gustavslundsvägen 42, 5 tr
Bromma AB 167 51
Sweden
Employees -
Website http://www.mobergpharma.se
Updated 07/08/2019
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers its products through the following brands: Kerasal, Kerasal Nail, Balmex, NewSkin, Dermoplast, Domeboro, and Fiber Choice. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.

Financials

View All
Created with Highcharts 5.0.14Moberg Pharma ABNet Income. Fiscal year is January-December. All values SEK Thousands.11 35811 35812 26812 26825 53725 53732 66832 66811 15811 15819 83819 838201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Moberg Pharma ABSales/Revenue. Fiscal year is January-December. All values SEK Thousands.157 389157 389200 180200 180285 566285 566334 304334 304439 032439 032439 041439 0412013201420152016201720180100k200k300k400k500k

Anna Yvonne Monica Malm Bernsten
Director
Sara Catherine Brandt
Director